Strategies and challenges for the next generation of antibody–drug conjugates
Center of Immunology Pierre Fabre · Hospices Civils de Lyon · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,141
total citations
- FWCI
- 98.42
- Percentile
- 100%
- References
- 178
Citations per year
Authors
4- ABAlain BeckCorresponding
Center of Immunology Pierre Fabre
- LGLiliane Goetsch
Center of Immunology Pierre Fabre
- CDCharles Dumontet
Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, Inserm, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique
- NCNathalie Corvaı̈a
Center of Immunology Pierre Fabre
Topics & keywords
Topics
Keywords
- Brentuximab vedotin
- Antibody-drug conjugate
- Drug
- Bioorthogonal chemistry
- Conjugate
- Drug development
- Pharmacology
- Medicine
No related works found for this paper.